Evoke Wealth LLC Makes New $1.36 Million Investment in Halozyme Therapeutics, Inc. (NASDAQ:HALO)

Evoke Wealth LLC purchased a new position in shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO – Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 36,657 shares of the biopharmaceutical company’s stock, valued at approximately $1,355,000. A number of other […]

Related Keywords

Belgium ,United States ,Boston ,Massachusetts ,Switzerland ,Japan ,Michaelj Labarre , ,Norges Bank ,Exchange Commission ,Securities Exchange Commission ,International Assets Investment Management ,Nasdaq ,Wafra Inc ,Halozyme Therapeutics Inc ,Harvey Capital Management Inc ,Evoke Wealth ,Halozyme Therapeutics ,Free Report ,Assets Investment Management ,Capital Management ,Get Free Report ,Halozyme Therapeutics Daily ,